The survival rates for pleural mesothelioma can vary based on several factors, including the stage at diagnosis, the patient’s overall health, treatment options, and the specific cell type of the mesothelioma.
Pleural mesothelioma has different cell types, mainly epithelioid, sarcomatoid, and biphasic (a mix of epithelioid and sarcomatoid cells). Here are approximate survival rates based on cell type:
- Epithelioid mesothelioma tends to have a better prognosis compared to other cell types.
- Patients with epithelioid cell type typically have a longer life expectancy after diagnosis.
- The median survival for epithelioid mesothelioma can range from around 12 to 24 months or more, depending on various factors.
- Sarcomatoid mesothelioma is more aggressive and less responsive to treatment compared to epithelioid type.
- The prognosis for sarcomatoid mesothelioma is generally poorer, with a shorter life expectancy following diagnosis.
- Survival rates for sarcomatoid mesothelioma can vary greatly but are often lower than for epithelioid type.
- Biphasic mesothelioma contains a mixture of both epithelioid and sarcomatoid cells.
- Survival rates for biphasic mesothelioma can vary based on the proportion of each cell type present in the tumor.
- Generally, the prognosis for biphasic mesothelioma falls between that of epithelioid and sarcomatoid types.
It’s important to note that these survival rates are approximate and can vary significantly among individuals. Other factors such as age, overall health, response to treatment, access to quality healthcare, and advancements in therapies also influence survival outcomes.
Always consult with healthcare professionals for accurate information and personalized prognosis as they can provide the most current and specific details based on an individual’s unique circumstances.